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The Mammary Gland: Protein Factory of
the Future
The lack of specific proteins can cause a
wide range of diseases including diabetes,
phenylketonuria, and cystic fibrosis. For
the last two decades, scientists have been
searching for ways to produce proteins that
have therapeutic value using biological
reactors. The unique secretary properties of
the mammary gland combined with the
ability to generate large, transgenic farm
animals such as cows, sheep, and pigs, pro-
vide scientists with innovative approaches
to produce large quantities of proteins in
milk. In addition to supplying proteins for
therapeutic uses, this technology has signif-
icant applications in environmental and
toxicological research. Bioengineering of
the mammary gland may be useful for
investigating potential effects of altered
human lactation due to maternal exposure
to environmental xenobiotics. The charac-
terization of milk protein genes has also
fostered investigations of the regulation of
oncogene expression and the induction of
cell proliferation by growth factors in
mammary tissue. As a consequence, the
mammary gland of experimental animals
has been genetically engineered to explore
the molecular mechanisms involved in the
development ofmammary tumors.
ASpecialized Secretory Gland
In evolutionary biology, lactogenesis, or
milk secretion, is considered one of the
most important functions for the survival of
mammals. Milk consumption by the new-
born is crucial during the early stages oflife.
Colostrum, which is produced by the mam-
mary gland postpartum, provides the new-
born with immunity and precious nutrients
that enhance survival. Normal development
of the mammary gland is essential to pro-
ducing sufficient milk to satisfy the nutri-
tional needs of the offspring, thus ensuring
the propagation ofthe species.
The mammary gland is a specialized
gland that synthesizes and secretes milk
components into the lumen (cavities) of
ducts. The ability to culture mammary
epithelial cells in the laboratory on compo-
nents ofbreast connective tissue in a petri
dish was a major step toward understand-
ing the cellular and molecular events that
cause mammary epithelial cells to differen-
tiate. Milk is secreted into small sacs
known as alveoli, which are embedded in
the connective tissue of mammary glands.
Alveolarlike structures, generally referred
to as mammospheres, can be generated by
culturing mammary epithelial cells.
Advances in molecular biology in the
last decade have provided biologists with a
better understanding ofthe developmental,
hormonal, cellular, and molecular mecha-
nisms that regulate the expression of milk
protein genes, namely, the caseins and
whey proteins. Approximately 90% of the
protein in the milk of dairy cows is
accounted for by four caseins and two
whey proteins. Expression of milk protein
genes is mediated through activation of
Mammary magic. Mammary epithelial cells secrete milk containing desired proteins into the lumen ofthe
mammosphere.
hormone-responsive elements (HRE) in
the promoter regions of a gene's DNA. A
variety of promoter elements have been
characterized that direct the expression of
milk protein genes. Two of the casein
genes, namely, Ox-casein and j3-casein, have
most likely evolved from a common ances-
tor gene, and the promoter region ofboth
genes contains HRE sequences that are
highly conserved. This evolutionary con-
servation of the HRE elements is of great
significance to mammary gland biotech-
nologists. The characterization of"univer-
sal" transcription regulatory sequences
("transcription modules") is an important
prerequisite to producing proteins in the
milk ofdifferent dairy species.
Bioengineering
To use the mammary gland as a bioreactor,
the transcription modules that drive the
expression ofproteins must meet two crite-
ria. First, the transcription modules must be
mammary specific, and second, expression
of the transgene must be under the same
developmental and hormonal controls that
coordinate the expression of milk protein
genes. For example, the onset oflactation is
marked by developmental and hormonal
events that shift the mammary gland from a
pregnant to a lactating state. Mammary
epithelial cells differentiate to form fully
developed lobulo-alveolar structures, and
after birth of the offspring, an increase in
circulating lactogenic hormones, specifically
glucocorticoid and prolactin, induces the
expression ofmilk protein genes.
The expression of foreign proteins in
milk of transgenic animals has most often
been accomplished by cloning DNA
encoding for the protein ofinterest down-
stream of DNA fragments that contain
defined transcriptional modules. However,
this strategy has not always produced large
quantities ofproteins because essential reg-
ulatory sequences are lacking in the DNA
of the transgene. Including additional
DNA domains and untranslated regions
and using genomic clones or minigenes
have resulted in enhanced and proper hor-
monal regulation oftransgene expression.
Sophisticated strategies have recently
been designed to confer appropriate devel-
opmental and hormonal regulation of
transgene expression to the mammary
gland. In particular, DNA sequences have
been identified that provide dominant reg-
ulation of gene expression, such as locus
control regions (LCR) and matrix attach-
ment regions (MAR). The LCR and MAR
elements may be useful in preventing loss
Environmental Health Perspectives 644FIe A. e
of expression if a transgene integrates in a
transcriptionally "silent" region of the
chromosomal DNA and in buffering the
influence ofnegative or positive regulatory
elements in the DNA.
A Bioreactor
The bioactivity of many proteins requires
post-translational modifications such as
glycosylation and carboxylation. These
complex modifications may not occur in
bacterial systems in such a way as to yield
proteins of desired potency. As a result,
proteins produced in bacteria may have to
be chemically manipulated before recombi-
nant proteins can be used for therapeutic
or industrial purposes. Using this tech-
nique, mammary epithelial cells have been
engineered to secrete proteins oftherapeu-
tic interest such as human protein C and
tissue plasminogen activator, important
mediators of hemostasis and coagulation,
and human a1-antitrypsin, which is
involved in emphysema.
Lactation and Environmental Health
Research
Using the mammary gland to produce pro-
teins may have important implications in
environmental health and neonatal toxicol-
ogy research. Transgenic mammary epithe-
lial cells could provide gene knock-out
models to investigate modulation of
expression in response to environmental
chemicals. Many environmental agents
appear to influence the physiology of the
lactating mammary gland. For instance,
tumor promoters such as phorbol esters
have deleterious effects on synthesis and
secretion ofmilk components, in particular
the caseins and the whey protein x-lactal-
bumin. The phorbol ester 12-0-tetrade-
canoylphorbol-13-acetate induces the
activity of the protein kinase C, which in
turn alters the phosphorylation of
cytoskeletal proteins. These changes lead to
dissociation ofprotein complexes necessary
for maintaining cell-cell contacts and
induce disruption ofcell morphology. As a
result, normal cells may take. on character-
istics of tumor cells. Other compounds
such as the potent dioxin TCDD may
compromise lipid synthesis and the secre-
tory activity ofthe mammarygland.
Potential Pitfalls
Because farm species are an integral com-
ponent of the natural ecologic system and
human microenvironment, the manipula-
tion ofthe genetic makeup ofthe mamma-
ry gland may be a concern. Using the
mammary gland ofanimals to manufacture
proteins may affect the health of the ani-
mals. For example, secretion oftissue plas-
minogen activator in goats' milk and whey
acidic protein in pigs' milk was associated
Therapeutic and Experimental Applications
Species Transgene Research Area
mouse human tissue plasminogen activator involved in regulation of hemostasis
e1 p~ and coagulation
human growth hormone potential paracrine effects on
mammarygrowth
human ax-antitrypsin regulates proteolytic degradation of
alvoelarwalls ofthe lungs, involved
in lung emphysema
hTGFcx growth factor, mammary neoplasia
Ha-ras oncogene, breast cancer
rabbit interleukin-2 stimulates T-cell proliferation
pig human protein c involved in regulation of
TM hemostasis and coagulation
sheep human factor IX zymogen of serine protease (FIXa)
involved in blood coagulation cascade
cow insulinlike growth factor-I growth factor, cell proliferation
Environmental Research Issues
Environmental Agent Research Area
phorbol esters tumorinduction, milksynthesis,
metabolism ofcytokeratins, cell
morphology, phosphorylation cascades
dioxins epidermal growth factor receptor,
lipid metabolism, phosphorylation
state, immune system
uridine Drivatives lactose synthesis
oxidizinoigents differentiated functions
insecticides neonatal toxicology
estrogenlike mammary development, lactation,
breast cancer
(Source: F.W. Kari, 1992 Workshop on the Effects on Environmental Chemicals on Lactation and the
Nursing Neonate, Executive Summary, National Institute of Environmental Health Sciences.)
with lactational shutdown immediately
after birth ofoffspring. al-Antitrypsin was
expressed in the salivary glands of trans-
genic mice when an ax-antitrypsin mini-
gene was under the control of a promoter
region ofthe ovine P-lactoglobulin gene.
It is also important to question whether
treatment of human subjects with recom-
binant milk-derived proteins may cause
undesirable side effects. Because recombi-
nant proteins produced by mammary epi-
thelial cells may have biological properties
other than the therapeutic one, potential
secondary effects on human health should
be carefully monitored. Health considera-
tions associated with direct human con-
sumption of milk produced by transgenic
animals, however, appear to be of moder-
ate concern because milk produced by
transgenic animals would be processed to
extract and purify the precious therapeutic
proteins.
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In addition, converting the mammary
gland into a bioreactor must be economically
advantageous. In this respect, the relatively
inefficient E. co/iand mammalian cell culture
models may soon be replaced by viral and
yeast systems that may render bioengineering
of the mammary gland economically ineffi-
cient. For instance, the yeast Pichia pastoris
has been used successfully for high-level
expression of recombinant proteins such as
tumor necrosis factor. Because Pichiapastoris
is a eukaryote, it can perform post-transla-
tional modifications similar to those carried
out by mammary cells.
The advantages of bioengineering the
mammary gland offarm animals are obvious
where the availability of large quantitites of
natural proteins is a limiting factor. Milk-
derived proteins ofpotential therapeutic and
nutritive value could be used for the treat-
ment of chronic and hereditary diseases.
Moreover, the use ofthe mammary gland as a
bioreactor may provide a model to investigate
the role of peptides involved in modulating
the effects of environmental xenobiotics in
human lactation and neonatal toxicity.
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